| | 141732-76-5 Basic information More.. |
| Product Name: | Exenatide acetate | | Synonyms: | His-Gly-Gly-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH{2};EXENATIDE ACETATE(EXENDIN-4);His-Gly-Gly-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2;Exenatide Acettate;EXENATIDE ACETATE;ENFUVIRTIDE ACETATE;Extendin-4;Unii-9p1872D4ol | | CAS: | 141732-76-5 | | MF: | C186H286N50O62S | | MW: | 4244.60796 | | EINECS: | 1592732-453-0 | | Mol File: | 141732-76-5.mol |  |
Use
Application of exenatideacetate causes an increase in acinar cAMP without stimulating amylase release. As an incretin mimetic, exenatideacetate acts as agonist of the glucagon-like peptide-1 (GLP-1) receptor. As GLP-1, though with prolonged activity, exenatideacetate augments the postprandial production of insulin and suppresses secretion of glucagon. For this reason, exenatideacetate has found use as a medication of diabetes II.
Application of exenatideacetate causes an increase in acinar cAMP without stimulating amylase release. As an incretin mimetic, exenatideacetate acts as agonist of the glucagon-like peptide-1 (GLP-1) receptor. As GLP-1, though with prolonged activity, exenatideacetate augments the postprandial production of insulin and suppresses secretion of glucagon. For this reason, exenatideacetate has found use as a medication of diabetes II.
Exenatide acetate is White Solid
- Exenatide Acetate
-
- $5.00
- 2026-09-17
- CAS:141732-76-5
- Min. Order: 1Box
- Purity: 99.99%
- Supply Ability: 20000 boxes
- exenatide
-
- $5.00
- 2026-09-17
- CAS:141732-76-5
- Min. Order: 1Box
- Purity: 99.99%
- Supply Ability: 20000 boxes
- Exenatide Acetate 1
-
- $5.00
- 2026-09-17
- CAS:141732-76-5
- Min. Order: 1Box
- Purity: 99.99%
- Supply Ability: 100000
|
|
141732-76-5
Recommend
Suppliers |
|
|
Recommend You Select Member Companies |
|
|